<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005248A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005248</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13989790</doc-number><date>20120702</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>D</subclass><main-group>207</main-group><subgroup>38</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>D</subclass><main-group>207</main-group><subgroup>38</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>514425</main-classification><further-classification>548548</further-classification><further-classification>548549</further-classification></classification-national><invention-title id="d0e43">NOVEL CHOLECYSTOKININ RECEPTOR LIGANDS</invention-title><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Balaram</last-name><first-name>Padijarethakkal N</first-name><address><city>Cochin</city><country>IN</country></address></addressbook><residence><country>IN</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Lattmann</last-name><first-name>Pornthip</first-name><address><city>Birmingham</city><country>GB</country></address></addressbook><residence><country>GB</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Balaram</last-name><first-name>Padijarethakkal N</first-name><address><city>Cochin</city><country>IN</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Lattmann</last-name><first-name>Pornthip</first-name><address><city>Birmingham</city><country>GB</country></address></addressbook></inventor></inventors></us-parties><pct-or-regional-filing-data><document-id><country>WO</country><doc-number>PCT/IN12/00469</doc-number><kind>00</kind><date>20120702</date></document-id><us-371c124-date><date>20130525</date></us-371c124-date></pct-or-regional-filing-data></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The present invention relates to novel compounds of formula (I):</p><p id="p-0002" num="0000"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="23.88mm" wi="50.04mm" file="US20140005248A1-20140102-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif"/></chemistry></p><p id="p-0003" num="0000">wherein<br/>X is selected from hydrogen, a halogen, or a substituent.<br/>and<br/>R is selected from hydrogen, a halogen, phenyl , aryl as specified<br/>and<br/>Y is selected from H, hydroxy, as specified<br/>and<br/>R<sup>1 </sup>is selected from H, methyl , alkyl, C<sub>1-18 </sub>straight, branched or cyclic, saturated, unsaturated and aromatic hydrocarbyl groups, which aromatic groups may be heterocyclic, cyclic or acyclic and which may optionally be substituted by alkyl, alkynyloxycarbonyl, aryl, benzyl, arlyoxy, arylcarbonyl, aryloxycarbonyl, sulphur equivalents of said oxy, carbonyl and oxycarbonyl moieties, and oxo as specified.</p><p id="p-0004" num="0000">The invention also relates to their uses as CCK receptor ligands and CCK antagonists and their medicinal applications.</p></abstract></us-patent-application>